Etonogestrel implant as a contraceptive choice; patient acceptability and adverse effect profile in a general practice setting

Irish Medical Journal

Volumn 102, Issue 1, 2009, Pages

  Riney, Sarah ^a,b   OShea, B ^a   Forde, A ^a  

^a The Bridge Medical Centre   (Ireland)

^b NONE   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ETONOGESTREL; LIDOCAINE; 3 KETO DESOGESTREL; 3-KETO-DESOGESTREL; CONTRACEPTIVE AGENT; DESOGESTREL;

ADULT; ARTICLE; ASEPSIS; ATTITUDE TO HEALTH; BLEEDING; COHORT ANALYSIS; CONTRACEPTIVE DEVICE; DEVICE REMOVAL; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GENERAL PRACTICE; HUMAN; IMPLANT; IRELAND; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MOOD DISORDER; QUESTIONNAIRE; SIDE EFFECT; TREATMENT DURATION; WEIGHT GAIN; ADOLESCENT; DIRECTIVE COUNSELING; GENERAL PRACTITIONER; PATIENT SATISFACTION; SEXUAL BEHAVIOR; STATISTICS; UTERUS BLEEDING;

ADOLESCENT; ADULT; COHORT STUDIES; CONTRACEPTION BEHAVIOR; CONTRACEPTIVE AGENTS, FEMALE; DESOGESTREL; DIRECTIVE COUNSELING; FEMALE; HUMANS; IRELAND; PATIENT SATISFACTION; PHYSICIANS, FAMILY; QUESTIONNAIRES; UTERINE HEMORRHAGE; YOUNG ADULT;

EID: 65349182424     PISSN: 03323102     EISSN: 03323102     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Organon M. SPC Implanon. Summary of Product Characteristics. Ireland 2008.
2. NICE. Clinical Guidelines. Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception. UK 2005.
3. Varney SJ, Guest JF. Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK. Pharmacoeconomics. 2004;22:1141-51.
4. Tolaymat LL, Kaunitz AM. Long-acting contraceptives in adolescents. Curr Opin Obstet Gynecol. 2007 Oct;19:453-60.
5. Power J, French R, Cowan F. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy. Cochrane Database Syst Rev. 2007:CD001326.
6. Hohmann H, Creinin MD. The contraceptive implant. Clin Obstet Gynecol. 2007 Dec;50:907-17.
7. Lakha F, Glasier AF. Continuation rates of Implanon in the UK: data from an observational study in a clinical setting. Contraception. 2006 Oct;74:287-9.
8. Bitzér J, Tschudin S, Alder J. Acceptability and side-effects of Implanon in Switzerland: a retrospective study by the Implanon Swiss Study Group. Eur J Contracept Reprod Health Care. 2004 Dec;9:278-84.
9. Weisberg E, Fraser I. Australian women’s experience with Implanon. Aust Fam Physician. 2005 Aug;34:694-6.
10. Funk S, Miller MM, Mishell DR, Jr., Archer DF, Poindexter A, Schmidt J, et al. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception. 2005 May;71:319-26.